Survival benefits of immunotherapy combined with chemoradiotherapy in metastatic colorectal cancer: an analysis based on data from the SEER database
Zhang Jie et al · De Gruyter · 2026
Accesso alla risorsa
Apri il contenuto dall’opzione principale o scegli un’altra fonte disponibile.
Accesso aperto disponibile
Riepilogo
Descripción general del contenido del recurso.
Come citare
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
al, Z. J. E. (2026). Survival benefits of immunotherapy combined with chemoradiotherapy in metastatic colorectal cancer: an analysis based on data from the SEER database. https://doi.org/10.1515/med-2026-1416
MLA
al, Zhang Jie et. "Survival benefits of immunotherapy combined with chemoradiotherapy in metastatic colorectal cancer: an analysis based on data from the SEER database." 2026. https://doi.org/10.1515/med-2026-1416.
Chicago
al, Zhang Jie et. 2026. "Survival benefits of immunotherapy combined with chemoradiotherapy in metastatic colorectal cancer: an analysis based on data from the SEER database.". https://doi.org/10.1515/med-2026-1416.
Harvard
al, Z. J. E. 2026, Survival benefits of immunotherapy combined with chemoradiotherapy in metastatic colorectal cancer: an analysis based on data from the SEER database, De Gruyter, available at: https://doi.org/10.1515/med-2026-1416 [Accessed 8 Aug. 2026].
Dettagli della risorsa
Informazioni bibliografiche utili per verificare che sia il materiale corretto.
- Titolo
- Survival benefits of immunotherapy combined with chemoradiotherapy in metastatic colorectal cancer: an analysis based on data from the SEER database
- Autore / collaboratori
- Zhang Jie et al
- Editore
- De Gruyter
- Anno di pubblicazione
- 2026
- ISSN
- 2391-5463
- ISSN
- 2391-5463
- Lingua
- Inglés
Soggetti
Esplora risorse correlate a partire da questi soggetti.